Safety and efficacy study of oral metronomic vinorelbine combined with trastuzumab (mNH) in HER2-positive metastatic breast cancer: a phase II trial
Zijing Wang(Qingdao University), Xu B(Chinese Academy of Medical Sciences & Peking Union Medical College), Jiayu Wang(Second Hospital of Shandong University), Qiao Li(Guangzhou University of Chinese Medicine), Qing Li(Army Medical University), Yang Luo(Chongqing University of Posts and Telecommunications), Pin Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Ying Fan(Hebei North University), Fei Ma(Chinese Academy of Medical Sciences & Peking Union Medical College), Jiaxuan Liu, Peng Yuan(Zhengzhou University)
Cited by 22
Related Papers
IL-2 regulates tumor-reactive CD8+ T cell exhaustion by activating the aryl hydrocarbon receptor
|Nature Immunology|2021|374
The roles of PPARγ and its agonists in autoimmune diseases: A comprehensive review
|Journal of Autoimmunity|2020|133
In Real Life, Low-Level HER2 Expression May Be Associated With Better Outcome in HER2-Negative Breast Cancer: A Study of the National Cancer Center, China
|Frontiers in Oncology|2022|119
PRDM1/BLIMP1 induces cancer immune evasion by modulating the USP22-SPI1-PD-L1 axis in hepatocellular carcinoma cells
|Nature Communications|2022|116
Inhibiting the redox function of APE1 suppresses cervical cancer metastasis via disengagement of ZEB1 from E-cadherin in EMT
|Journal of Experimental & Clinical Cancer Research|2021|107